Dr. Richard A. Rosenbloom, M.D., Ph.D., offers pharmaceutical and medical consulting, specializing in clinical drug development, pharmacovigilance, medical affairs, and the formulation of botanical, nutraceutical, and medical food products.
Dr. Richard A. Rosenbloom, M.D., Ph.D., provides specialized pharmaceutical and medical consulting services, drawing on over twenty years of experience in clinical drug development. His practice focuses on medical affairs, pharmacovigilance, and the development of pharmaceutical, botanical, and nutraceutical products, including medical foods and functional foods. His consulting capabilities span protocol design, investigator selection, clinical study strategy, regulatory affairs, and medical marketing. Dr. Rosenbloom also maintains an extensive portfolio of international patents covering treatments for conditions such as diabetic neuropathy, radiation injury, and viral infections.
These services support pharmaceutical companies and research organizations by bridging the gap between scientific formulation and clinical application. By leveraging his expertise in both the clinical and regulatory aspects of drug development, he assists clients in navigating the complexities of bringing therapeutic entities from research to market. His past work includes leadership roles in contract research organizations and direct experience with multi-phase international clinical trials, providing a comprehensive resource for organizations managing product development, safety monitoring, and the strategic commercialization of medical treatments.